• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter: tofacitinib use for biologic-refractory paediatric inflammatory bowel disease.

作者信息

Dolinger Michael T, Rolfes Priya, Phan Becky L, Dubinsky Marla C

机构信息

Department of Pediatric Gastroenterology, Susan and Leonard Feinstein IBD Clinical Center, Icahn School of Medicine at Mount Sinai, New York.

出版信息

Aliment Pharmacol Ther. 2019 Oct;50(8):966-967. doi: 10.1111/apt.15496.

DOI:10.1111/apt.15496
PMID:31591772
Abstract
摘要

相似文献

1
Letter: tofacitinib use for biologic-refractory paediatric inflammatory bowel disease.信函：托法替布用于生物制剂难治性儿童炎症性肠病
Aliment Pharmacol Ther. 2019 Oct;50(8):966-967. doi: 10.1111/apt.15496.
2
The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease.Janus 激酶抑制剂在炎症性肠病中的未来。
J Crohns Colitis. 2017 Jul 1;11(7):885-893. doi: 10.1093/ecco-jcc/jjx003.
3
The use of tofacitinib in the treatment of inflammatory bowel disease.托法替布在炎症性肠病治疗中的应用。
Immunotherapy. 2018 Aug;10(10):837-849. doi: 10.2217/imt-2018-0015. Epub 2018 Apr 27.
4
Management of refractory cutaneous dermatomyositis: potential role of Janus kinase inhibition with tofacitinib.难治性皮肤性皮肌炎的治疗：托法替尼的 Janus 激酶抑制作用的潜在作用。
Rheumatology (Oxford). 2019 Jun 1;58(6):1011-1015. doi: 10.1093/rheumatology/key366.
5
The use of Tofacitinib in the treatment of inflammatory bowel disease.托法替布在炎症性肠病治疗中的应用。
Ter Arkh. 2019 Mar 18;91(2):101-108. doi: 10.26442/00403660.2019.02.000155.
6
Tofacitinib: a new oral Janus kinase inhibitor for psoriasis.托法替布：一种用于治疗银屑病的新型口服 Janus 激酶抑制剂。
Br J Dermatol. 2019 Jan;180(1):13-14. doi: 10.1111/bjd.17323.
7
Effectiveness and Safety of Combining Tofacitinib With a Biologic in Patients With Refractory Inflammatory Bowel Diseases.托法替布与生物制剂联合用于难治性炎症性肠病患者的有效性和安全性
Inflamm Bowel Dis. 2021 Oct 18;27(10):1698-1702. doi: 10.1093/ibd/izab112.
8
Long-term safety data for tofacitinib, an oral Janus kinase inhibitor, for the treatment for psoriasis.口服 Janus 激酶抑制剂托法替布治疗银屑病的长期安全性数据。
Br J Dermatol. 2018 Oct;179(4):815-816. doi: 10.1111/bjd.17016.
9
Efficacy of topical tofacitinib, a Janus kinase inhibitor, in the treatment of plaque psoriasis.托法替布（一种Janus激酶抑制剂）局部用药治疗斑块状银屑病的疗效。
Dermatol Ther. 2017 May;30(3). doi: 10.1111/dth.12467. Epub 2017 Jan 30.
10
Reversal of Alopecia Universalis by Tofacitinib: A Case Report.托法替布治疗全秃症逆转：一例报告
Ann Intern Med. 2016 Nov 15;165(10):750-751. doi: 10.7326/L16-0125.

引用本文的文献

1
The Role of Tofacitinib in the Treatment of Acute Severe Colitis in Children.托法替布在儿童急性重症结肠炎治疗中的作用。
J Can Assoc Gastroenterol. 2023 Nov 6;7(2):196-203. doi: 10.1093/jcag/gwad042. eCollection 2024 Apr.
2
A Review of Therapeutic Escalation for Pediatric Patients Admitted for Inflammatory Bowel Disease Flares.炎症性肠病发作入院小儿患者治疗升级的综述
J Pediatr Pharmacol Ther. 2023;28(7):649-657. doi: 10.5863/1551-6776-28.7.649. Epub 2023 Nov 23.
3
Dual-Targeted Therapy in Pediatric Inflammatory Bowel Disease: A Comprehensive Review.
儿科炎症性肠病的双靶向治疗：全面综述。
Paediatr Drugs. 2023 Sep;25(5):489-498. doi: 10.1007/s40272-023-00579-6. Epub 2023 Jun 15.
4
The New Molecules Are Changing the Course of Pediatric Chronically Active Ulcerative Colitis: A Series of Pediatric Cases.新型分子正在改变儿童慢性活动性溃疡性结肠炎的病程：一系列儿科病例
JPGN Rep. 2021 Jul 12;2(3):e100. doi: 10.1097/PG9.0000000000000100. eCollection 2021 Aug.
5
Tofacitinib to Treat Severe Acute Refractory Colitis in a Teenager: Case Report and Review of the Literature.托法替布治疗青少年重度急性难治性结肠炎：病例报告及文献综述
JPGN Rep. 2022 Aug 16;3(3):e241. doi: 10.1097/PG9.0000000000000241. eCollection 2022 Aug.
6
Favorable Outcomes Combining Vedolizumab With Other Biologics or Tofacitinib for Treatment of Inflammatory Bowel Disease.维多珠单抗与其他生物制剂或托法替布联合治疗炎症性肠病的良好结局
Crohns Colitis 360. 2021 Jun 9;3(3):otab030. doi: 10.1093/crocol/otab030. eCollection 2021 Jul.
7
[Recent research on tofacitinib in the treatment of pediatric rheumatic diseases].[托法替布治疗儿童风湿性疾病的最新研究]
Zhongguo Dang Dai Er Ke Za Zhi. 2022 Apr 15;24(4):447-453. doi: 10.7499/j.issn.1008-8830.2201081.
8
Tofacitinib for a Child with Refractory Steroid-Dependent Ulcerative Colitis: A Case Report and Review of the Literature.托法替布治疗儿童难治性激素依赖型溃疡性结肠炎 1 例报告并文献复习
Am J Case Rep. 2021 Nov 12;22:e934460. doi: 10.12659/AJCR.934460.
9
It Takes Two to Make It Right: Dual Biologic and Small Molecule Therapy for Treatment-Refractory Pediatric Inflammatory Bowel Disease.需要两者结合才能成功：双生物制剂与小分子药物联合治疗难治性小儿炎症性肠病
Inflamm Bowel Dis. 2021 Jul 27;27(8):1361-1362. doi: 10.1093/ibd/izaa279.
10
The Management Approach to the Adolescent IBD Patient: Health Maintenance and Medication Considerations.青少年炎症性肠病患者的管理方法：健康维护与药物考量
Curr Gastroenterol Rep. 2020 Jan 29;22(1):5. doi: 10.1007/s11894-019-0739-9.